Immune Checkpoint Inhibitors in Cancer, 1st Edition
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.
!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!
!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.
特長
- Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages.
- Helps you translate current research and literature into practical information for daily practice.
- Presents information logically organized by disease site.
- Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks.
- Consolidates today’s available information on this timely topic into one convenient resource.
著者情報
| ISBN Number | 9780323549486 |
|---|---|
| Description Author List | Edited by Fumito Ito, MD, PhD, Associate Professor of Oncology, Department of Surgical Oncology, Member, Center for Immunotherapy, Roswell Park Cancer Institute; Associate Professor of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Marc Ernstoff, MD, Professor and Chair, Department of Medicine, Senior Vice President for Clinical Investigation, The Katherine Anne Gioia Chair of Medicine, Roswell Park Cancer Institute and Chief, Division of Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffaclo, New York |
| Copyright Year | 2019 |
| Edition Number | 1 |
| Format | Book |
| Trim | 191w x 235h (7.50" x 9.25") |
| Imprint | Elsevier |
| Page Count | 256 |
| Publication Date | 22 Aug 2018 |
| Stock Status | IN STOCK |


eBooks : Built for busy schedules & tailored for your goals.


Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.


Seamless access wherever you are


Always in sync


Tools the make learning stick
Your eBook is ready whenever you are!
1. Check your email for your access code.


2. Sign into or create your VitalSource account and redeem your code.


3. Open your eBook - ready whenever you are!
FAQ
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
Any questions ?
Top Picks from Our Community
電子書籍
Elsevier
Dec 2025
電子書籍
Mary Alice Statkiewicz Sherer
Dec 2025
電子書籍
Monica Breedlove
Dec 2025
電子書籍
Matthew Buckland
Dec 2025
電子書籍
電子書籍
Margaret J. Fehrenbach
Dec 2025
電子書籍
電子書籍
電子書籍
Edited by Ragavendra R. Baliga
Nov 2025
電子書籍
Linda Anne Silvestri
Nov 2025
電子書籍
Elsevier
Nov 2025
電子書籍
Elsevier Inc and Jackie Koesterman
Jan 2025
電子書籍
Edited by Asaad Beshish
Nov 2025
電子書籍
Edited by Aziz Shaibani
Nov 2025
電子書籍
Edited by Jordi Vega
Oct 2025
電子書籍
Edited by Nabil Elkassabany
Nov 2025
電子書籍
電子書籍
Edited by Hannah Yong Wen
Nov 2025
電子書籍
Edited by Britta Leise
Nov 2025
1. Tumor Immunology
2. Melanoma and Other Skin Cancers
3. Thoracic Malignancies
4. Gastrointestinal, Hepatobiliary, and Pancreatic Malignancies
5. Cancers of the Head and Neck
6. Urologic Malignancies
7. Gynecologic Malignancies
8. Breast Cancer
9. Hematologic Malignancies
10. Pediatric Malignancies
11. Toxicities Associated with Immune Checkpoint Inhibitors
12. Future of Immune Checkpoint Inhibitors
"Overall, this is an informative and authoritative book that includes experiences from clinicians and scientists working at some of the most renowned cancer centers in the world."
-Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 100-5 Stars!





